ea0092ps2-15-01 | Hyperthyroidism | ETA2023
Cosentino Giada
, Lanzolla Giulia
, Comi Simone
, Menconi Francesca
, Rotondo Dottore Giovanna
, Novella Maglionico Maria
, Posarelli Chiara
, Figus Michele
, Elisei Rossella
, Santini Ferruccio
, Marino Michele
Objectives: Optimal treatment for GravesÂ’ hyperthyroidism (GH) in patients with moderate-to-severe, active GravesÂ’ orbitopathy (GO) remains to be established. There is debate on whether a conservative (antithyroid drugs, ATDs) or an ablative approach (radioactive iodine, RAI, or surgery, Tx)has to be preferred. The aim of the present study was to investigate whether these different approachesresult in a different outcome of GOfollowing intravenous glucocorticoids (iv...